However, more recently, Son et al., 2021 found that TGF-β reduces soluble CX3CL1, which in turn affects OSCC bone invasion and improves patient survival, indirectly suggesting that CX3CL1 also has pro-cancer effects in OSCC. Here, CX3CL1 is linked to cancer.